Quest Diagnostics to Add Roche's Elecsys to Alzheimer's Biomarker Test Portfolio

MT Newswires Live

昨天

Quest Diagnostics (DGX) said Monday it is adding Roche's Elecsys Phospho-Tau Plasma blood test to its AD-Detect portfolio of biomarker tests to detect Alzheimer's disease.

The company said it plans to offer a laboratory test service based on Elecsys in Q4 and incorporate the Roche test into future AD-Detect panels in 2027.

Quest said the US Food and Drug Administration has cleared Roche's Elecsys blood test to assess amyloid pathology associated with Alzheimer's disease across primary and specialty care settings.

Quest also said it will launch its newest AD-Detect lab-developed blood test with low 10% indeterminate rate so more patients can receive an actionable insight.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/news/2661276223"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2661276223\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2661276223?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-24 20:24","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2661276223","market":"sh","top_or_hot":-1,"title":"Quest Diagnostics to Add Roche's Elecsys to Alzheimer's Biomarker Test Portfolio","media":"MT Newswires Live","content":"<html><body><p> Quest Diagnostics (DGX) said Monday it is adding Roche's Elecsys Phospho-Tau Plasma blood test to its AD-Detect portfolio of biomarker tests to detect Alzheimer's disease.</p><p>The company said it plans to offer a laboratory test service based on Elecsys in Q4 and incorporate the Roche test into future AD-Detect panels in 2027.</p><p>Quest said the US Food and Drug Administration has cleared Roche's Elecsys blood test to assess amyloid pathology associated with Alzheimer's disease across primary and specialty care settings.</p><p>Quest also said it will launch its newest AD-Detect lab-developed blood test with low 10% indeterminate rate so more patients can receive an actionable insight.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Quest Diagnostics to Add Roche's Elecsys to Alzheimer's Biomarker Test Portfolio</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nQuest Diagnostics to Add Roche's Elecsys to Alzheimer's Biomarker Test Portfolio\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-08-24 20:24</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Quest Diagnostics (DGX) said Monday it is adding Roche's Elecsys Phospho-Tau Plasma blood test to its AD-Detect portfolio of biomarker tests to detect Alzheimer's disease.</p><p>The company said it plans to offer a laboratory test service based on Elecsys in Q4 and incorporate the Roche test into future AD-Detect panels in 2027.</p><p>Quest said the US Food and Drug Administration has cleared Roche's Elecsys blood test to assess amyloid pathology associated with Alzheimer's disease across primary and specialty care settings.</p><p>Quest also said it will launch its newest AD-Detect lab-developed blood test with low 10% indeterminate rate so more patients can receive an actionable insight.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU2506951958.HKD","symbol_name":"BNP PARIBAS SUSTAINABLE GLOBAL LOW VOL EQUITY \"CRH\" (HKDHDG) INC","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2661276223","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2661276223","pubTimestamp":1787574276,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Quest Diagnostics  said Monday it is adding Roche's Elecsys Phospho-Tau Plasma blood test to its AD-Detect portfolio of biomarker tests to detect Alzheimer's disease.The company said it plans to offer a laboratory test service based on Elecsys in Q4 and incorporate the Roche test into future AD-Detect panels in 2027.Quest said the US Food and Drug Administration has cleared Roche's Elecsys blood test to assess amyloid pathology associated with Alzheimer's disease across primary and specialty care settings.Quest also said it will launch its newest AD-Detect lab-developed blood test with low 10% indeterminate rate so more patients can receive an actionable insight.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU2506951958.HKD":"BNP PARIBAS SUSTAINABLE GLOBAL LOW VOL EQUITY \"CRH\" (HKDHDG) INC","LU1854104046.USD":"M&G (LUX) POSITIVE IMPACT \"A\" (USD) ACC","LU1854103824.USD":"M&G (LUX) POSITIVE IMPACT \"A\" (USD) INC","LU2506951875.HKD":"BNP PARIBAS SUSTAINABLE GLOBAL LOW VOL EQUITY \"CRH\" (HKDHDG) ACC","BK4567":"ESG概念","BK4196":"保健护理服务","BK4583":"猴痘概念","LU0823417653.USD":"BNP PARIBAS SUSTAINABLE GLOBAL LOW VOL EQUITY \"C\" (USD) ACC","BK4585":"ETF&股票定投概念","LU0950375773.USD":"BNP PARIBAS SUSTAINABLE GLOBAL LOW VOL EQUITY \"C\" (USD) INC A","BK4588":"碎股","DGX":"奎斯特诊疗","LU2506952097.USD":"BNP PARIBAS SUSTAINABLE GLOBAL LOW VOL EQUITY \"CRH\" (USDHDG) ACC","LU2506952170.USD":"BNP PARIBAS SUSTAINABLE GLOBAL LOW VOL EQUITY \"CRH\" (USDHDG) INC","LU0823417737.USD":"BNP PARIBAS SUSTAINABLE GLOBAL LOW VOL EQUITY \"C\" (USD) INC"},"translate_title":"Quest Diagnostics 将罗氏 Elecsys 添加到阿尔茨海默氏症生物标志物测试产品组合中","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"DGX":1.5},"content_text":"Quest Diagnostics (DGX) said Monday it is adding Roche's Elecsys Phospho-Tau Plasma blood test to its AD-Detect portfolio of biomarker tests to detect Alzheimer's disease.The company said it plans to offer a laboratory test service based on Elecsys in Q4 and incorporate the Roche test into future AD-Detect panels in 2027.Quest said the US Food and Drug Administration has cleared Roche's Elecsys blood test to assess amyloid pathology associated with Alzheimer's disease across primary and specialty care settings.Quest also said it will launch its newest AD-Detect lab-developed blood test with low 10% indeterminate rate so more patients can receive an actionable insight.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}